coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Strood PCN, Medway (LAD) · Health Inequalities Profile

    PCN U27664 · NHS Kent and Medway Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    41,588

    Registered population

    60.6% aged 18–64

    16.2%

    Aged 65+

    ICB 19.9% · England 17.9%

    16.6%

    Ethnic minority (non-White)

    6.8% Asian · England 9.6%

    12.8%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~5,052

    Core20 residents (est.)

    Resident basis; registered basis ~5,320 · see page 3

    6,549

    Hypertension register

    +6.05% in 3 yrs · England +5.60%

    335

    SMI register

    11.8% of Medway (LAD)'s

    671

    COPD register

    Reviews -0.72% in 3 yrs

    Forecast to 2030

    7,624

    Hypertension patients, 2030

    +1,075 on today

    73.0%

    QRISK ≥20% on statins, 2030

    +4.19pp over 3 yrs

    4.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -10.9%
    Asthma annual review completion fell over three years.

    Completion fell 10.9% over 2023 to 2025 (England +4.4%) to 58.1%, leaving about 980 patients unreviewed; this may reflect recall capacity, testable by audit.

    69.6%
    SMI blood pressure checks trail England and Medway.

    Coverage is 69.6% (England 83.4%; Medway 75.5%), down 0.9 pp over 2023 to 2025, with Apex Medical Centre at 61.1% and Court View Surgery.

    +12.1%
    Hypertension control improved faster than national and local.

    Treatment to threshold rose +12.1% over 2023 to 2025 (England +3.6%; Medway +2.7%) to 66.6%, with under-80 blood pressure control up +13.1%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger registered list contrasts with heavy local care home bed capacity

    Strood PCN serves 41,588 registered patients. The population is younger than benchmarks: 23.1% are aged 0-17, above Medway (21.6%), the ICB (20.7%) and England (19.6%), while 16.2% are aged 65+, below Medway (17.9%), the ICB (19.9%) and England (17.9%). Census usual residents in associated areas are 83.4% White (Medway 84.3%, the ICB 88.6%, England 81.1%) and 16.6% from ethnic minority backgrounds, including 6.8% Asian and 5.3% Black residents. These residential Census proportions may not match registered patient demographics but provide baseline context for service planning.

    Age profile

    0–1723.1%
    18–6460.6%
    65+16.2%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White83.4%
    Asian6.8%
    Black5.3%
    Mixed3.0%
    Other1.5%

    Older people · falls rows are Medway (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Medway LA)1,5072,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)75.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Medway LA)7409819552024/25
    Falls deaths, all ages, per 100,000 (Medway LA)19.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 12.8% overall but ranges by 30.6 percentage points across practices

    Strood PCN’s Core20 share is 12.8%, below Medway (23.1%), England (21.0%) and NHS Kent and Medway ICB (17.1%). The Core20 share spans 30.6 pp across practices: Court View Surgery records 30.6% (3,164 estimated patients), while Riverside Medical Practice and Borstal Village Surgery both record 0.0%. City Way Surgery accounts for 1,176 estimated patients (9.0%) and Apex Medical Centre accounts for 980 (14.7%). Resident estimates (5,052) and practice-derived totals (5,320) use non-additive bases.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Court View30.6% · 3,164 patients
    Apex14.7% · 980 patients
    City Way9.0% · 1,176 patients
    Riverside Medical0.0% · 0 patients
    Borstal Village0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    335

    SMI register

    0.79% recorded prevalence

    349

    Learning disability register

    0.82% recorded prevalence

    34

    Care homes, 1,025 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Medway (LAD), Census 2021

    Learning disability prevalence is 0.8% (349 patients), above Medway (0.7%), the ICB (0.6%) and England (0.6%). Severe mental illness prevalence is 0.8% (335 patients), below Medway (0.9%), the ICB (0.9%) and England (1.0%). The catchment contains 34 care homes with 1,025 beds, though resident registration is unconfirmed. Crude recorded prevalence differences do not establish unmet need, under-detection, or coding quality.

    Severe mental illness: physical health checks

    SMI blood pressure checks fell 0.9 pp over 2023 to 2025 (England +4.4 pp) to 69.6% (England 83.4%), reaching 61.1% at Apex Medical Centre, 61.5% at Court View Surgery, and 67.4% at City Way Surgery.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,549

    Hypertension register

    +6.05%

    Register growth, 3 yrs

    Medway (LAD) +3.74% · England +5.60%

    +7.39pp

    BP control, under 80

    ≤140/90 · +7.68pp aged 80+

    +1,075

    More patients by 2030

    Forecast 7,624 (17.40%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 15.5% (6,549 patients), compared to Medway (15.4%) and England (15.2%). Blood pressure treated to target rose +12.1% over 2023 to 2025 (England +3.6%) to 66.6%, trailing England (70.3%). Recent blood pressure readings reach 89.1% (England 90.0%). Blood pressure control under age 80 improved +13.1% (England +3.2%) to 63.8% (England 67.8%), and in ages 80 and over rose +10.9% (England +2.2%) to 78.2% (England 81.2%). Observation periods for current counts are unstated. While blood pressure control is improving faster than nationally, persistent shortfalls against England highlight an opportunity to prioritise titration recall for patients under 80.

    Lipids and statins

    Lipid-lowering therapy reaches 63.7% of QRISK ≥ 20% patients (England 63.6%), rising +7.0% over 2023 to 2025 (England +6.2%). In diabetes without CVD, uptake is 72.3% (England 73.2%). Observation periods are unstated. Auditing diabetic lipid therapy presents a targeted opportunity where coverage trails national levels.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202668,686£1.70£1.90£1.86£116,766
    Cardiovascular (all), 202585,396£2.47£3.57£3.33£210,928

    In 2026, the PCN prescribed 68,686 lipid-regulating items at £1.70 per item (£116,766 total spend), below Medway (£1.87), England (£1.86), and NHS Kent and Medway ICB (£1.90). The PCN spent £10,990 less than at England's unit cost across 68,686 items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −10.86%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.16%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 10.9% over 2023 to 2025 (England +4.4%) to 58.1% (England 65.7%), leaving about 980 of 2,328 registered patients without a recorded review. Recorded COPD prevalence is 1.6% (England 1.9%), falling 6.7% over 2023 to 2025 (England +2.6%), while annual COPD reviews reached 75.4% (England 76.4%). Second-hand smoking status was recorded for 81.9% of asthma patients aged 6-19 (England 78.8%). Observation periods for current registers are unstated.

    Cancer register and children's immunisation

    The cancer register expanded +16.9% over 2023 to 2025 (England +9.0%) to 1,526 patients (3.6% prevalence, England 3.8%). In Q1 2025/26, age-5 MMR dose 1 coverage was 94.3% (England 91.7%) but dose 2 was 84.3% (England 82.8%), a 10 pp dose drop-off. Pre-school 4-in-1 booster coverage was 80.7%, below the 95.0% target by 14.3 pp. Re-engaging families before school entry is critical to close booster gaps.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.2%

    England 91.0%

    6-in-1 complete primary course at 24 months91.0%

    England 92.2%

    MMR dose 1 at 24 months86.1%

    England 88.3%

    MMR dose 2 at age 584.3%

    England 82.8%

    4-in-1 pre-school booster at age 580.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (England 55.3%), sitting 19.4 pp below the national 75.0% ambition. Reaching 75.0% would require about 1,630 extra early-stage cases a year across the ICB, where the early-stage share rose +2.2 pp between 2013 and 2022. Only 63.6% of registered cancers had a known stage (England 67.0%), meaning staging coverage is incomplete. System staging figures reflect the wider ICB rather than PCN performance. At PCN level, Strood PCN's cancer register expanded +16.9% over 2023 to 2025 (England +9.0%) to 1,526 patients.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Medway NHS Foundation Trust achieved 81.6% against the 85.0% 62-day cancer standard, ahead of NHS Kent and Medway Integrated Care Board (75.9%) and England (71.2%), while Maidstone and Tunbridge Wells NHS Trust reached 87.4% and Dartford and Gravesham NHS Trust 63.6%. Medway met the 28-day faster diagnosis standard at 77.8% and 31-day standard at 99.6%. For diagnostics, 6-week waits were 0.0% for CT and 0.7% for MRI, but cardiology echocardiography reached 36.6% (England 28.5%). Provider waits describe system capacity rather than PCN delivery, highlighting where diagnostic delays could affect secondary care workup.

    Pathways within standard (%)MedwayMaidstone and Tunbridge WellsDartford and GraveshamKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7781.7878.1476.7879.32
    31-day treatment (96%)99.6298.3597.4895.8492.50
    62-day referral to treatment (85%)81.6487.4363.5975.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMaidstone and Tunbridge WellsDartford and GraveshamEngland
    MRI0.680.920.3621.40
    CT0.000.512.089.92
    Echocardiography36.622.573.9028.48
    Colonoscopy1.8819.800.4030.83
    Gastroscopy3.3224.030.0029.02
    All 15 DM01 tests14.206.428.3723.14
    Community services activityMedway residentsKent and Medway ICB
    Care contacts43,510254,055
    Referrals8,58068,085
    Patients with a contact11,54072,060

    Community services (residents of Medway), Jun 2026 (provisional). In Jun 2026, 62% of community service contacts with Medway borough residents were for adults aged 65 and over (26,985 of 43,510 contacts). These provisional figures capture local authority resident activity rather than PCN-specific delivery, describing wider borough activity rather than PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient phone access spans 62.7 pp across practices from 23.8% to 86.5%

    In 2025/26, overall QOF achievement ranged from 88.8% at Riverside Medical Practice to 95.5% at Court View Surgery (England 92.5%). Vaccination and immunisation achievement spanned 44.3 pp, from 15.8% at City Way Surgery to 60.2% at Court View Surgery (England 55.2%). All-domain personalised care adjustments reached 13.1% at City Way Surgery against 5.3% at Riverside Medical Practice.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Riverside Medical840.085.6%86.2%88.3%
    Borstal Village950.086.5%70.1%82.4%
    Court View Surgery10530.635.0%81.0%67.3%
    Apex9714.735.6%70.2%63.9%
    City Way Surgery1349.023.8%77.6%54.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNMedway (LAD)AssetPCNMedway (LAD)
    Care homes (catchment)34 (1,025 beds)n/aSchools (catchment)88n/a
    Children's centres519Places of worship45110
    Libraries19Food banks (VCS)26
    Homelessness support (VCS)39Day centres (VCS)1429
    Children and young people (VCS)2265Carers support groups (VCS)1022
    Primary schools (LA maintained)717Primary academies2156

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall

    Asthma reviews fell 10.9% over 2023 to 2025 to 58.1% across 2,328 registered patients (about 980 unreviewed), trailing Medway (62.6%) and England (65.7%). For discussion: practices could run a single-template asthma recall prioritising unreviewed patients, offering after-school or flexible review slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check outreach

    SMI blood pressure checks fell 0.9 pp over 2023 to 2025 to 69.6% across 335 registered patients (Medway 75.5%, ICB 79.7%, England 83.4%), and BMI recording is 69.6% (England 82.1%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    COPD register validation and case-finding

    COPD prevalence is 1.6% (671 patients), below Medway (1.7%), England (1.9%) and the ICB (2.0%), falling 6.7% over 2023 to 2025 (England +2.6%); benchmark gap range is +56 to +117. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric capacity review (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Targeted Core20 outreach deployment (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Primary care cancer pathway review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephony and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 3 · COPD register validation and case-finding (p12)COPD register · COPD: QOF prevalence · Registered populationCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15